• To enhance your understanding of the link between diabetes and systemic anticancer therapy (SACT)
• To read about the knowledge base and confidence levels of healthcare staff working in oncology and caring for patients with, or who are at high risk of developing, diabetes while also undergoing SACT
• To acknowledge the need for training in diabetes management for healthcare staff working in oncology
In the UK, the incidence of cancer and diabetes mellitus is increasing, and this is predicted to continue as the population ages. When an individual presents with both cancer and diabetes and requires systemic anticancer therapy (SACT) this can lead to higher susceptibility to infections and increased risk of hospitalisation, particularly if the diabetes is not well managed. This is in part attributed to the frequent use of corticosteroids to manage the side-effects of SACT, such as nausea, which can induce hyperglycaemia.
This article describes a service evaluation that aimed to examine the knowledge base and confidence levels of healthcare professionals working in an oncology setting and caring for patients who have, or who are at high risk of developing, diabetes while also undergoing SACT. The findings suggest that knowledge in this field varies significantly across professions and that there is a need for training in diabetes management for those working in oncology settings.
Cancer Nursing Practice. doi: 10.7748/cnp.2024.e1880
Peer reviewThis article has been subject to external double-blind peer review and checked for plagiarism using automated software
Correspondence Conflict of interestNone declared
Osgood L, Gityamwi N, Cooke D (2025) Evaluating oncology healthcare professionals’ knowledge of diabetes mellitus. Cancer Nursing Practice. doi: 10.7748/cnp.2024.e1880
Published online: 16 December 2024
or
Are you a student? Our student subscription has content especially for you.
Find out more